Advanced NanoTherapies

Private

Santa Clara-based clinical-stage medtech company developing SirPlux Duo, the first nanoparticle-coated dual-drug (paclitaxel + sirolimus) balloon platform for coronary and peripheral artery disease.

Company

Founded
2018
Headquarters
Santa Clara, USA

Financials

Total Funding
$31M

Funding History

1 round
Series B Jun 2, 2026
$31M

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.